Orbimed Advisors - SINGULAR GENOMICS SYSTEMS IN ownership

SINGULAR GENOMICS SYSTEMS IN's ticker is OMIC and the CUSIP is 82933R100. A total of 75 filers reported holding SINGULAR GENOMICS SYSTEMS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of SINGULAR GENOMICS SYSTEMS IN
ValueSharesWeighting
Q3 2023$206,006
-54.1%
540,6970.0%0.00%
-50.0%
Q2 2023$448,779
-31.4%
540,6970.0%0.01%
-38.5%
Q1 2023$654,243
-39.8%
540,6970.0%0.01%
-38.1%
Q4 2022$1,086,801
-19.6%
540,6970.0%0.02%
-16.0%
Q3 2022$1,352,000
-34.5%
540,6970.0%0.02%
-32.4%
Q2 2022$2,065,000
-85.8%
540,697
-76.5%
0.04%
-84.3%
Q1 2022$14,518,000
-40.3%
2,300,792
+9.3%
0.24%
-24.9%
Q4 2021$24,326,000
+8.8%
2,104,359
+5.3%
0.31%
+27.2%
Q3 2021$22,363,000
-59.3%
1,998,5210.0%0.25%
-55.7%
Q2 2021$54,919,0001,998,5210.56%
Other shareholders
SINGULAR GENOMICS SYSTEMS IN shareholders Q3 2022
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 3,798,926$7,635,8411.96%
Tikvah Management LLC 316,854$636,8770.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,450,871$12,966,2510.27%
Triatomic Management LP 155,411$312,3760.26%
Casdin Capital, LLC 1,345,722$2,704,9010.21%
Perceptive Advisors 3,282,275$6,597,3730.18%
Oasis Management Co Ltd. 221,729$445,6750.09%
PLATINUM INVESTMENT MANAGEMENT LTD 881,068$1,770,9470.07%
Anson Funds Management LP 169,747$341,1910.06%
Weil Company, Inc. 53,202$106,9360.05%
View complete list of SINGULAR GENOMICS SYSTEMS IN shareholders